Skip to main content
OpenTrials

Clinical trial condition

Alagille Syndrome

Explore clinical trials studying Alagille Syndrome. Study availability and eligibility vary by location and protocol.

28 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Alagille Syndrome trial results

Recruiting

Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation

NCT07335523

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +20 more
Locations
  • Children's Hospital Colorado - Research Institute Aurora, Colorado, United States
  • Pediatric GI of El Paso El Paso, Texas, United States
  • Hassenfeld Children's Hospital at NYU Langone New York, United States
  • Research Institute at Nationwide Children's Hospital Columbus, Ohio, United States
View Trial Details
Recruiting

A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

NCT07585097

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +11 more
Locations
  • Hospices Civils de Lyon - Hopital Femme Mere Enfant Bron, France
  • CHU Dijon Bourgogne Dijon, France
  • APHP - Hopital Bicetre - Paris Sud Le Kremlin-Bicêtre, France
  • APHM - CHU Timone Marseille, France
View all 14 locations
View Trial Details
Recruiting

A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

NCT06850038

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • The Children's Mercy Hospital Kansas City, Missouri, United States
  • SSM Health Cardinal Glennon Children's Hospital St Louis, Missouri, United States
View Trial Details
Recruiting

Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)

NCT07290257

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +19 more
Locations
  • Cliniques Universitaires Saint Luc (UCLouvain) Brussels, Belgium
  • University Hospital Gent (UZ Gent) Ghent, Belgium
  • Hospices Civils de Lyon - Hopital Femme Mère Enfant Bron, Auvergne-Rhône-Alpes, France
  • CHU de Toulouse - Hôpital des Enfants Toulouse, Occitanie, France
View all 15 locations
View Trial Details
Recruiting

Pediatric Evaluation and Registry for Liver Cholestasis in Canada

NCT07411716

Conditions
Abnormalities, Multiple, Alagille Syndrome, Alagille Syndrome (ALGS), +14 more
Locations
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Stollery Children's Hospital Edmonton, Alberta, Canada
  • BC Children's Hospital Vancouver, British Columbia, Canada
  • HSC Winnipeg Children's Hospital Winnipeg, Manitoba, Canada
View all 13 locations
View Trial Details
Recruiting

Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

NCT06193928

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +13 more
Locations
  • Children's Hospital Los Angeles CHLA Los Angeles, California, United States
  • Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics and the Digestive Health Institute, Children's Hospital of Colorado and University of Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta - Emory University School of Medicine Atlanta, Georgia, United States
  • Children's Mercy Kansas City, Department of Gastroenterology, Section of Hepatology Kansas City, Missouri, United States
View Trial Details

Related conditions